Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan-Reference-Cited by-同舟云学术

Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan

Published:2017-08-16 Issue:10 Volume:27 Page:1060-1066
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Kao Wei-Heng¹^ORCID,Hong Ji-Hong¹²³,See Lai-Chu⁴,Yu Huang-Ping⁵,Hsu Jun-Te⁶,Chou I-Jun⁷,Chou Wen-Chi⁸,Chiou Meng-Jiun⁹,Wang Chun-Chieh¹²,Kuo Chang-Fu⁹¹⁰

Affiliation:

1. Department of Radiation Oncology; Chang Gung Memorial Hospital; Taoyuan Taiwan

2. Department of Medical Imaging and Radiological Science; Chang Gung University; Taoyuan Taiwan

3. Radiation Biology Research Center, Institute for Radiological Research; Chang Gung University and Chang Gung Memorial Hospital; Taoyuan Taiwan

4. Department of Public Health, College of Medicine; Chang Gung University; Taoyuan Taiwan

5. Department of Anaesthesiology; Chang Gung Memorial Hospital; Taoyuan Taiwan

6. Department of General Surgery; Chang Gung Memorial Hospital; Taoyuan Taiwan

7. Department of Paediatrics; Chang Gung Memorial Hospital; Taoyuan Taiwan

8. Department of Haemato-oncology; Chang Gung Memorial Hospital; Taoyuan Taiwan

9. Division of Rheumatology, Allergy and Immunology; Chang Gung Memorial Hospital; Taoyuan Taiwan

10. Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine; University of Nottingham; Nottingham UK

Funder

Chang Gung Memorial Hospital, Linkou

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.4267/fullpdf

Reference26 articles.

1. Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease;Chiang;Int J Clin Oncol,2016

2. A population-based cost analysis of thoracoscopic versus open lobectomy in primary lung cancer;Wang;Ann Surg Oncol,2016

3. Association between 131I treatment for thyroid cancer and risk of receiving cataract surgery: a cohort study from Taiwan;Lin;J Nucl Med,2016

4. Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes;Tseng;Eur J Clin Invest,2016

5. Use of radioactive iodine for thyroid cancer and risk of second primary malignancy: a nationwide population-based study;Teng;J Natl Cancer Inst,2016

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of colchicine on cancer risk in patients with immune-mediated inflammatory diseases: a time-dependent study based on the Taiwan’s National Health Insurance Research Database;European Journal of Medical Research;2024-04-22

2. Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study;European Urology Focus;2024-03

3. Severity of Complications and Duration of Type 2 Diabetes and the Risk of Cancer: A Population-Based Study;Cancer Epidemiology, Biomarkers & Prevention;2024-02-27

4. Age at lung cancer diagnosis in females versus males who never smoke by race and ethnicity;British Journal of Cancer;2024-02-22

5. Effect of colchicine on cancer risk in patients with the musculoskeletal system and connective tissue and rheumatism-related diseases;2024-01-02